Takeda Pharmaceutical (TAK) Enterprise Value: 2017-2025

Historic Enterprise Value for Takeda Pharmaceutical (TAK) over the last 9 years, with Mar 2025 value amounting to $44.5 billion.

  • Takeda Pharmaceutical's Enterprise Value rose 10.13% to $44.5 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $29.6 billion, marking a year-over-year increase of 54.02%. This contributed to the annual value of $44.5 billion for FY2025, which is 10.36% up from last year.
  • As of FY2025, Takeda Pharmaceutical's Enterprise Value stood at $44.5 billion, which was up 10.36% from $40.3 billion recorded in FY2024.
  • Takeda Pharmaceutical's 5-year Enterprise Value high stood at $47.4 billion for FY2021, and its period low was $37.0 billion during FY2022.
  • Over the past 3 years, Takeda Pharmaceutical's median Enterprise Value value was $44.5 billion (recorded in 2025), while the average stood at $43.9 billion.
  • Its Enterprise Value has fluctuated over the past 5 years, first dropped by 22.03% in 2022, then climbed by 27.10% in 2023.
  • Takeda Pharmaceutical's Enterprise Value (Yearly) stood at $47.4 billion in 2021, then declined by 22.03% to $37.0 billion in 2022, then grew by 27.10% to $47.0 billion in 2023, then decreased by 14.25% to $40.3 billion in 2024, then grew by 10.36% to $44.5 billion in 2025.